Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done for biopharma and medtech companies.

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Q3 2019 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal landscape.

In this report, you can find an overview and analysis of the following across the biopharma markets in the US, Europe, and Asia (Japan and China):

•  Key performance indicators for the biopharma market
• IPO and private financing activity and performance
• Deal activity for strategic partnership and M&A
• A look ahead and our predictions of the future